Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for B9M384

Entry ID Method Resolution Chain Position Source
AF-B9M384-F1 Predicted AlphaFoldDB

No variants for B9M384

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for B9M384

No associated diseases with B9M384

1 regional properties for B9M384

Type Name Position InterPro Accession
domain Aminotransferase, class I/classII 35 - 405 IPR004839

Functions

Description
EC Number 2.6.1.83 Transaminases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
L,L-diaminopimelate aminotransferase activity Catalysis of the reaction: 2-oxoglutarate + LL-2,6-diaminopimelate = (S)-2,3,4,5-tetrahydrodipicolinate + L-glutamate + H(2)O + H(+).
pyridoxal phosphate binding Binding to pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.

1 GO annotations of biological process

Name Definition
lysine biosynthetic process via diaminopimelate, diaminopimelate-aminotransferase pathway The chemical reactions and pathways resulting in the formation of lysine, via the intermediate diaminopimelate; in this pathway tetrahydrodipicolinate is converted to meso-diaminopimelate in two enzymatic steps.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAKINDNYLK LKAGYLFPEI GRRVRAFAEA NPSAKVIRLG IGDVTRPLAP AVLKAFHDAV
70 80 90 100 110 120
DDLATTDKFA GYGPEQGYDW LINAIIDKSY KPLGVSLKTE EIFISDGSKC DCANILDIFA
130 140 150 160 170 180
MDNVVAIGDP VYPVYNDTNV MIGRTGEADE KGYYKGIVYM PCNEANGFIP ELPKEKVDII
190 200 210 220 230 240
YLCFPNNPTG TVASKAELKK WVDYANANDA VIFFDAAYEA FITDPSIPHS IYEIEGAKKC
250 260 270 280 290 300
AIEFRSFSKT AGFTGVRCGL VVVPEEVMGT TADGERYSFN RLWLRRTTTK FNGASYPVQR
310 320 330 340 350 360
AAAAVYSDEG WKQTKEVIDY YMENARIIRE GLKEVGVTVF GGVDAPYIWL KTPGGMTSWD
370 380 390 400
FFDKLLTECN VVGTPGSGFG PSGEGYFRLS AFGHRENVIE AVERIKKNLK